Application of the ANRORC-Process for the Directional Synthesis of 5-Ureido-2-Pyrazolines as a Biologically Active Co-Ligand of Gold Glyconanoparticles

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Interaction of 1-phenyl-4,6-dimethylpyrimidine-2(1H)-one with 4-mercaptobuturic acid hydrazide proceeds as ANRORC (Addition of the Nucleophile–Ring Opening–Ring Closure) process and gives in the formation with 60% yield of 1-(4-mercaptobutanoyl)-3,5-dimethyl-5-(3-phenylcarbamoylamino)-2-pyrazoline as promising сo-ligand for the preparation of gold glyconanoparticles for biomedical purposes.

Full Text

Restricted Access

About the authors

A. Y. Ershov

Institute of Macromolecular Compounds of the Russian Academy of Sciences

Email: martynenkoff@gmail.com
ORCID iD: 0000-0002-2266-4380
Russian Federation, Bol′shoi prosp., 31, St. Petersburg, 199004

A. A. Martynenkov

Institute of Macromolecular Compounds of the Russian Academy of Sciences

Author for correspondence.
Email: martynenkoff@gmail.com
ORCID iD: 0000-0002-0951-1451
Russian Federation, Bol′shoi prosp., 31, St. Petersburg, 199004

I. V. Lagoda

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: martynenkoff@gmail.com
ORCID iD: 0000-0002-3906-2909
Russian Federation, Lesoparkovaya ul., 4, St. Petersburg, 195043

A. A. Batyrenko

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: martynenkoff@gmail.com
ORCID iD: 0000-0001-9688-3650
Russian Federation, Lesoparkovaya ul., 4, St. Petersburg, 195043

References

  1. Glycochemical synthesis: strategies and applications. Ed. S.-C. Hung, M. M. L. Zulueta. Hoboken, New Jersey: John Wiley & Sons Inc. 2016. doi: 10.1002/978 1119006435.ch16
  2. Mu W., Chu Q., Liu Y., Zhang N. Nano-Micro Lett. 2020, 12, е142. doi: 10.1007/s40820-020-00482-6
  3. Boije af Gennäs G., Mologni L., Ahmed S., Rajaratnam M., Marin O., Lindholm N., Viltadi M., Gambacorti-Passerini C., Scapozza L., Yli-Kauha-luoma J. Chem. Med. Chem. 2011, 6, 1680–1692. doi: 10.1002/cmdc.2011 00168
  4. Matiadis D., Sagnou M. Int. J. Mol. Sci. 2020, 21, e5507. doi: 10.3390/ijms21155507
  5. Naim M.J., Alam O., Nawaz F., Alam J., Alam P. J. Pharm. Bioallied Sci. 2016, 8, 2–17. doi: 10.4103/0975-7406.171694
  6. Jazayeri M.H., Amani H., Pourfatollah A.A., Avan A., Ferns G.A., Pazoki-Toroudi H. Cancer Gene Ther. 2016, 23, 365–369. doi: 10.1038/cgt.2016.42
  7. Ershov A.Y., Koshmina N.V. Arkivoc, 2000, vi, 917–922. doi: 10.3998/ark.5550190.0001.609
  8. Ершов А.Ю., Гиндин В.А., Грибанов А.В. ЖОрХ. 1997, 33, 438–441. [Ershov A.Y., Gindin V.V., Gribanov A.V. Russ. J. Org. Chem. 1997, 33, 388–391]. https:// www.pleiades. online/abstract/orgchem/97/orgchem0388_abstract.pdf
  9. van der Plas H.C. Adv. Heterocycl. Chem., 1999, 74, 87–151. doi: 10.1016/S0065-2725(08)60810-7
  10. Цаплин Г.В., Попков С.В. ЖOрХ. 2022, 58, 6–22. [Tsaplin G.V., Popkov S.V. Russ. J. Org. Chem. 2022, 58, 1–14.] doi: 10.1134/S1070428022010018
  11. Kashima C., Katoh A., Yokota Y., Omote Y. Chem. Pharm. Bull. 1981, 29, 2516–2519.
  12. doi: 10.1248/cpb.29.2516
  13. von Delius M., Geertsema E.M., Leigh D.A. Nat. Chem. 2010, 2, 96–101. doi 10.1038/ nchem.481.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Scheme

Download (132KB)
3. Figure from Contents

Download (51KB)

Copyright (c) 2025 Russian Academy of Sciences